As of 2024, the blood and blood-forming organs medicine market in Germany is forecasted to grow considerably. With sales at 7.2 billion euros in 2024, projections indicate progressive increases to 9.71 billion euros by 2028. This demonstrates a consistent year-on-year rise averaging around 6-7% annually, showcasing a solid growth trajectory in this sector.
Looking forward, key trends to monitor include advances in personalized medicine and biotechnology, potential healthcare policy changes, and demographic shifts such as an aging population, which could further influence demand and innovation within the market.
